|
|
|||||||||
NEWS & VIEWS |
In October 2004, after our issue of CA went to press, the DEA removed the document from its Web site and asked the two pain groups that had posted it to do the same. The agency said the document contained "misstatements" and was being revised. At press time for this issue of CA, the DEA had not yet clarified the nature of those misstatements but said an interim statement about the situation would be forthcoming.
"DEA recognizes that the proper use of controlled substances in the treatment of pain remains an extremely important issue. Accordingly, DEA intends to address this matter in the future," a notice on the agencys Web site said.
David Joranson, MSSW, Director of the Pain and Policy Studies Group, and Russell Portenoy, MD, Chairman of Beth Israels Department of Pain Medicine and Palliative Care, said they agreed to remove the document from their respective Web sites until the DEA further explained its actions. Both men were in the working group that created the document.
"We would not want to continue to disseminate a document that was inaccurate," Portenoy said. He expressed disappointment, however, at the turn of events.
The DEA, he said, had not given any of the clinicians involved in writing the document advance notice that it would be removed from its Web site nor had the agency yet discussed any changes it wished to make to the document with the others involved.
"The actions that have been taken appear on the surface to undermine several years work in establishing better communication between DEA and the clinical community," he said.
This article has been cited by other articles:
![]() |
R. C Tiwari, L. X Clegg, and Z. Zou Efficient interval estimation for age-adjusted cancer rates Statistical Methods in Medical Research, December 1, 2006; 15(6): 547 - 569. [Abstract] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | COVER ARCHIVE | SEARCH | TABLE OF CONTENTS |